Malaria

The device is targeted at severely ill malaria patients who have been hospitalised and prescribed IV drug treatment. These are the most vulnerable patients, including children, pregnant women and immune deficient patients, and can have mortality rates up to 20%.

Latest News

MediSieve wins Investment Achievement Award at MedTech London Awards 2019

MediSieve wins Investment Achievement Award at MedTech London Awards 2019
Created on 13-05-2019

  MediSieve , the medical device company developing ‘magnetic blood filtration', has won the ...
Hospitoons Animation - Raising Awareness on World Malaria Day

Hospitoons Animation - Raising Awareness on World Malaria Day
Created on 25-04-2019

As we support #WorldMalariaDay today, take a look at our animation.